MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Syneos Health®SYNCH, the only fully integrated biopharmaceutical solutions company, today announced the appointment of William E. Klitgaard to its board of directors. Mr. Klitgaard was previously a member of Syneos’ Board of Directors from 2017 to May 2022 after resigning due to a personal matter. The Company also announced today that Todd M. Abbrecht is retiring from its Board of Directors.
“We are pleased to welcome Bill back to the Syneos Health Board,” said John Dineen, Chairman of the Syneos Health Board of Directors. “Bill’s deep financial background coupled with his knowledge of our business is a welcome addition to an already strong board that is improving its composition. This appointment will support the continued successful oversight of our strategy as we accelerate the delivery of important therapies to patients by our customers.”
Mr. Dineen added, “Syneos Health has been served well by Todd’s contributions and we thank him for his years of service to the company.”
Mr. Klitgaard will serve as a Class II Director and as a member of the Company’s Audit Committee. With these changes, the Syneos Health Board continues to consist of 10 directors, 9 of whom are independent.
William E. Klitgaard
Mr. Klitgaard currently serves on the Boards of Directors of XIFIN, Inc., a healthcare information technology company, and Avista Public Acquisition Corp. II, a special purpose acquisition company, where he serves as Chairman of the Audit Committee.
Mr. Klitgaard was Operating Executive at Avista Capital Partners, a private equity firm focused on healthcare, from 2020-2021. He was previously President of Enlighten Health, a division of LabCorp, from 2015-2016. He also served in various roles over his 19-year career at Covance, including three years as corporate senior vice president and chief information officer and nearly 12 years as corporate senior vice president and chief financial officer. He received his Bachelor of Arts…
